Skip to main content
Top
Published in: Rheumatology International 2/2008

01-12-2008 | Original Article

Higher LPS-stimulated TNF-α mRNA levels in peripheral blood mononuclear cells from Chinese ankylosing spondylitis patients with −308G/A polymorphism in promoter region of tumor necrosis factor: association with distinct A33/B58/Cw10 haplotypes

Authors: Ming-Chi Lu, K. L. Yang, Chien-Hsueh Tung, Kuang-Yung Huang, Hui-Chun Yu, Su-Qin Liu, Ning-Sheng Lai

Published in: Rheumatology International | Issue 2/2008

Login to get access

Abstract

To investigate the effects of TNF-α −308, −238 promoter polymorphisms on TNF-α transcription in B27 positive Chinese patients with ankylosing spondylitis (AS). The possible relationship between polymorphisms, MHC antigens, and quantitative TNF-α mRNA expression were evaluated. Single nucleotide polymorphisms (SNPS) of TNF-α −308 and −238 were performed by PCR-amplification refractory mutation system method (PCR-ARMS) in sixty-seven B27-positive AS patients and 60 HLA-B27 positive healthy controls in Chinese. Quantitative measurement of TNF-α mRNA in peripheral blood mononuclear cells was performed with real time RT-PCR. The polymorphisms were correlated to quantitative TNF-α mRNA, and MHC antigens (determined by SSP method) in AS patients. The prevalence rate of both −308G/A and −238G/A TNF-α promoter polymorphisms in patients were not significantly different from those in normal subjects. However, a significant high LPS-stimulated TNF-α mRNA expression was found in peripheral blood mononuclear cells from patients with promoter −308G/A polymorphism (TNF2) as compared to those in −308G/G genotype (TNF1). Furthermore, −308G/A polymorphism in patients was found to be tightly associated with distinct haplotypes of A33/B58/Cw10 [12 out of 14 –308G/A patients (85.7%) versus none in 53 –308G/G patients], independent of B27 antigen. HLA-A33-B58-Cw10 haplotypes associated TNF-α promoter −308G/A polymorphism might play an important role in disease pathogenesis of AS in Chinese population, partially related to a driving force of a higher TNF-α production. It confirms once again the importance and complexity of MHC related molecules in disease pathogenesis of AS.
Literature
2.
4.
go back to reference Brown M, Pile KD, Kennedy LG et al (1998) A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum 41:588–595PubMedCrossRef Brown M, Pile KD, Kennedy LG et al (1998) A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum 41:588–595PubMedCrossRef
5.
go back to reference Beutler B (1995) TNF, immunity and inflammatory disease:lessons of the past decade. J Invest Med 43:227–235 Beutler B (1995) TNF, immunity and inflammatory disease:lessons of the past decade. J Invest Med 43:227–235
7.
go back to reference Grom AA, Murray KJ, Luyrink L et al (1996) Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovial fluid of patients with juvenile rheumatoid arthritis and juvenile rheumatoid arthritis and juvenile spondyloarthropathies. Arthritis Rheum 39:1703–1710. doi:10.1002/art.1780391013 PubMedCrossRef Grom AA, Murray KJ, Luyrink L et al (1996) Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovial fluid of patients with juvenile rheumatoid arthritis and juvenile rheumatoid arthritis and juvenile spondyloarthropathies. Arthritis Rheum 39:1703–1710. doi:10.​1002/​art.​1780391013 PubMedCrossRef
9.
10.
go back to reference D’Alfonso S, Richiardi PM (1994) A polymorphic variation in a putative regulation box of the TNF-α promoter region. Immunogenetics 39:150–155PubMed D’Alfonso S, Richiardi PM (1994) A polymorphic variation in a putative regulation box of the TNF-α promoter region. Immunogenetics 39:150–155PubMed
12.
go back to reference Rosenbaum JT (1992) Acute anterior uveitis and spondylopathy. Rheum Dis Clin North Am 18:143–152PubMed Rosenbaum JT (1992) Acute anterior uveitis and spondylopathy. Rheum Dis Clin North Am 18:143–152PubMed
15.
16.
17.
go back to reference GeneAmp® 5700 sequence detection system user’s manual (PE Biosystems) (1999) Chap. 4, p A1–A30 GeneAmp® 5700 sequence detection system user’s manual (PE Biosystems) (1999) Chap. 4, p A1–A30
18.
go back to reference Lai NS, Liu SQ, Yu H, Gong YZ et al (2006) Quantitative measurement of HLA-B27 mRNA in patients with ankylosing spondylitis––correlation with clinical activity in patients. J Rheumatol 33:1128–1132PubMed Lai NS, Liu SQ, Yu H, Gong YZ et al (2006) Quantitative measurement of HLA-B27 mRNA in patients with ankylosing spondylitis––correlation with clinical activity in patients. J Rheumatol 33:1128–1132PubMed
20.
go back to reference Pociot F, Briant L, Jongeneel CV et al (1993) Association of tumor necrosis factor and class II major histocompatibility comples alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 23(1):224–231. doi:10.1002/eji.1830230135 PubMedCrossRef Pociot F, Briant L, Jongeneel CV et al (1993) Association of tumor necrosis factor and class II major histocompatibility comples alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 23(1):224–231. doi:10.​1002/​eji.​1830230135 PubMedCrossRef
22.
go back to reference Mäkelä S, Mustonen J, Ala-Houhala I et al (2002) Human leukocyte antigen-B3-DR3 is a more importnat risk factor for severe Puumala hantavirus infection than the tumor necrosis factor alpha(−308) G/A polymorphism. J Infect Dis 186(6):843–846. doi:10.1086/342413 PubMedCrossRef Mäkelä S, Mustonen J, Ala-Houhala I et al (2002) Human leukocyte antigen-B3-DR3 is a more importnat risk factor for severe Puumala hantavirus infection than the tumor necrosis factor alpha(−308) G/A polymorphism. J Infect Dis 186(6):843–846. doi:10.​1086/​342413 PubMedCrossRef
23.
go back to reference Nadel S, Newport MJ, Booy R et al (1996) Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 174:878–880PubMed Nadel S, Newport MJ, Booy R et al (1996) Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 174:878–880PubMed
24.
25.
go back to reference Kaijzel EL, van Krugten MV, Brinkman BMN et al (1998) Functional analysis of a human TNF-α promoter polymorphism related to joint damage in rheumatoid arthritis. Mol Med 4:724–733PubMed Kaijzel EL, van Krugten MV, Brinkman BMN et al (1998) Functional analysis of a human TNF-α promoter polymorphism related to joint damage in rheumatoid arthritis. Mol Med 4:724–733PubMed
26.
go back to reference Deleuran BW, Chu CQ, Field M et al (1992) Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis: implications for local actions of tumor necrosis factor. Arthritis Rheum 35:1170–1178. doi:10.1002/art.1780351009 PubMedCrossRef Deleuran BW, Chu CQ, Field M et al (1992) Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis: implications for local actions of tumor necrosis factor. Arthritis Rheum 35:1170–1178. doi:10.​1002/​art.​1780351009 PubMedCrossRef
28.
go back to reference Bertolini DR, Nedwin GE, Bringman TS et al (1986) Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature 319:516–518. doi:10.1038/319516a0 PubMedCrossRef Bertolini DR, Nedwin GE, Bringman TS et al (1986) Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature 319:516–518. doi:10.​1038/​319516a0 PubMedCrossRef
30.
go back to reference Abraham LJ, Kroeger KM (1999) Impact of the −308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 66(4):562–566PubMed Abraham LJ, Kroeger KM (1999) Impact of the −308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 66(4):562–566PubMed
31.
go back to reference Price P, Bolitho P, Jaye A et al (2003) A Gambian TNF haplotypes matches the European HLA-A1, B8, DR3 and Chinese HLA-A33, B58, DR3 haplotypes. Tissue Antigens 62(1):72–75PubMedCrossRef Price P, Bolitho P, Jaye A et al (2003) A Gambian TNF haplotypes matches the European HLA-A1, B8, DR3 and Chinese HLA-A33, B58, DR3 haplotypes. Tissue Antigens 62(1):72–75PubMedCrossRef
32.
go back to reference Shaw CK, Chang TK, Chen SN et al (1997) HLA polymorphism and probability of HLA-matched unrelated marrow donors for Chinese in Taiwan. Tissue Antigens 50:610–619PubMedCrossRef Shaw CK, Chang TK, Chen SN et al (1997) HLA polymorphism and probability of HLA-matched unrelated marrow donors for Chinese in Taiwan. Tissue Antigens 50:610–619PubMedCrossRef
Metadata
Title
Higher LPS-stimulated TNF-α mRNA levels in peripheral blood mononuclear cells from Chinese ankylosing spondylitis patients with −308G/A polymorphism in promoter region of tumor necrosis factor: association with distinct A33/B58/Cw10 haplotypes
Authors
Ming-Chi Lu
K. L. Yang
Chien-Hsueh Tung
Kuang-Yung Huang
Hui-Chun Yu
Su-Qin Liu
Ning-Sheng Lai
Publication date
01-12-2008
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 2/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0671-z

Other articles of this Issue 2/2008

Rheumatology International 2/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.